+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Mexico Magnetic Resonance Imaging (MRI) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 92 Pages
  • August 2026
  • Region: Mexico
  • Mordor Intelligence
  • ID: 6266247
The mexico mRI market size is expected to grow from USD 186.64 million in 2025 to USD 194.06 million in 2026 and is forecast to reach USD 235.87 million by 2031 at 3.98% CAGR over 2026-2031. This report is Segmented by Architecture (Closed MRI Systems, Open MRI Systems), Field Strength (Low-Field ≤0. 4T, High-Field 1. 5T, Very-High 3T & Ultra-High ≥7T), Application (Neurology, Oncology, Musculoskeletal, Cardiology & Vascular, Other Clinical Applications), and Geography (Mexico). The Market Forecasts are Provided in Terms of Value (USD).

Mexico Magnetic Resonance Imaging (MRI) Market Trends and Insights

Advancements in MRI Hardware and AI-Enabled Software

Rapid algorithmic innovation is shrinking scan times by up to 50%, allowing facilities to raise daily throughput without adding scanners. Siemens Healthineers’ AI-Rad Companion and Philips’ SmartSpeed Precise platforms sharpen images while trimming protocol length, which directly offsets the radiologist shortfall by reducing repeat studies. Helium-free magnet designs such as Philips BlueSeal systems curb lifetime operating expenses by removing volatile cryogen inputs, and more than 1,000 units have been installed worldwide. Mexico’s universal electronic-health-record program positions facilities to exploit AI workflow engines that draw on integrated data lakes for automated triage, further lifting scanner productivity. FDA-cleared software such as SwiftMR is vendor-agnostic, enabling hospitals to retrofit legacy fleets instead of replacing entire systems.

Rising Chronic and Oncological Disease Burden

Diabetes affected 16.9% of Mexican adults in 2022 and is projected to climb steadily through 2050, necessitating periodic renal, cardiac and neurologic imaging follow-ups. Cardiovascular mortality increased from 96.7 to 111.7 per 100,000 between 2011-2015, making MRI pivotal for ischemic and structural heart assessments. Cancer incidence stands at 140.9 per 100,000, with breast and prostate leading new-case tallies, and oncology MRI volumes are growing fastest as screening guidelines widen. Chronic kidney disease linked to diabetes impacts 14.5 million residents, driving repeat abdominal MRI studies for disease-progress tracking. Long COVID affects 37% of survivors, adding respiratory and neurologic MRI demand for lingering complications.

High Upfront and Lifecycle Cost of MRI Scanners

Premium 3 T platforms require capital outlays above USD 2 million, and facility modifications, helium refills and annual service contracts can double total ownership cost over ten years. With 41.37% of health spending paid out of pocket, many mid-size hospitals postpone upgrades or resort to refurbished imports that carry shorter warranties. Peso volatility magnifies budgeting risk because most coils, gradients and electronics are priced in U.S. dollars, causing leasing rates to swing alongside exchange-rate shifts. Public institutions face multi-year budget cycles that delay tender launches and prolong replacement of aging 1 T fleets. Helium-free magnets offer energy savings of 40 MWh per year per system, trimming operating expenses yet still demand high sticker prices that challenge cash-constrained providers.

Other drivers and restraints analyzed in the detailed report include:

  • Expansion of Private Hospitals and Medical-Tourism Clusters
  • Federal Tax Breaks and USMCA Import Incentives
  • Shortage and Uneven Distribution of Trained Radiologists

Segment Analysis

Closed scanners delivered 67.65% of Mexico MRI market revenue in 2025, reflecting hospital preference for higher field strengths and multi-sequence versatility that support complex neuro, cardiac and oncologic protocols. Facilities catering to medical tourists use closed platforms to advertise comprehensive head-to-toe packages that rival premium U.S. imaging centers. Patient-centric design pressures, however, underpin a 4.65% CAGR for open systems through 2031, as claustrophobic, bariatric and pediatric cohorts seek more comfortable environments.

Open platforms led by Fujifilm Aperto Lucent add motion-compensating sequences and permanent magnets that lower energy use, making them attractive for mid-size regional hospitals. Closed systems evolve in parallel; Canon Medical’s Vantage Galan 3 T Supreme Edition integrates AI protocols that slash scan times and minimize helium usage. As facility portfolios widen, executives mix open units for outpatient comfort with closed units for high-throughput tertiary care, anchoring balanced long-term demand across both architectures.

Complete Report Scope:

  • By Architecture
    • Closed MRI Systems
    • Open MRI Systems
  • By Field Strength
    • Low-Field (≤0.4 T)
    • High-Field (1.5 T)
    • Very-High (3 T) & Ultra-High (≥7 T)
  • By Application
    • Neurology
    • Oncology
    • Musculoskeletal
    • Cardiology & Vascular
    • Other Clinical Applications

List of Companies Covered in this Report:

  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips
  • Canon
  • FUJIFILM
  • Esaote
  • Fonar
  • United Imaging Healthcare
  • Hitachi
  • Samsung NeuroLogica
  • Neusoft Medical Systems
  • Hyperfine
  • Bruker BioSpin
  • Time Medical Systems
  • Aspect Imaging
  • Shenzhen Anke High-tech
  • Mediso Medical Imaging
  • Aurora Imaging Tech
  • Esaote-Mindray JV
  • AllTech Medical Systems
  • Paramed Medical Systems

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Advancements In MRI System Hardware & AI-Enabled Software
4.2.2 Rising Burden Of Chronic & Oncological Diseases
4.2.3 Expansion Of Private Hospitals & Medical-Tourism Clusters
4.2.4 Federal Tax Breaks & USMCA Import Incentives For Imaging Devices
4.2.5 Rapid Roll-Out Of Teleradiology & Pacs Across Secondary Cities
4.2.6 Oem Near-Shoring Of Coil & Magnet Sub-Assembly Lines
4.3 Market Restraints
4.3.1 High Upfront & Lifecycle Cost Of MRI Scanners
4.3.2 Lengthy Cofepris Device-Registration & Reimbursement Delays
4.3.3 Peso Volatility Inflating Lease-Financing Costs
4.3.4 Shortage & Uneven Distribution Of Trained Radiologists
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter’s Five Forces
4.7.1 Bargaining Power of Buyers
4.7.2 Bargaining Power of Suppliers
4.7.3 Threat of New Entrants
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Architecture
5.1.1 Closed MRI Systems
5.1.2 Open MRI Systems
5.2 By Field Strength
5.2.1 Low-Field (=0.4 T)
5.2.2 High-Field (1.5 T)
5.2.3 Very-High (3 T) & Ultra-High (=7 T)
5.3 By Application
5.3.1 Neurology
5.3.2 Oncology
5.3.3 Musculoskeletal
5.3.4 Cardiology & Vascular
5.3.5 Other Clinical Applications
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 GE HealthCare
6.3.2 Siemens Healthineers
6.3.3 Philips Healthcare
6.3.4 Canon Medical Systems
6.3.5 Fujifilm Healthcare
6.3.6 Esaote SpA
6.3.7 Fonar Corporation
6.3.8 United Imaging Healthcare
6.3.9 Hitachi Medical Systems
6.3.10 Samsung NeuroLogica
6.3.11 Neusoft Medical Systems
6.3.12 Hyperfine Inc.
6.3.13 Bruker BioSpin
6.3.14 Time Medical Systems
6.3.15 Aspect Imaging
6.3.16 Shenzhen Anke High-tech
6.3.17 Mediso Medical Imaging
6.3.18 Aurora Imaging Tech
6.3.19 Esaote-Mindray JV
6.3.20 AllTech Medical Systems
6.3.21 Paramed Medical Systems
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • GE HealthCare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon Medical Systems
  • Fujifilm Healthcare
  • Esaote SpA
  • Fonar Corporation
  • United Imaging Healthcare
  • Hitachi Medical Systems
  • Samsung NeuroLogica
  • Neusoft Medical Systems
  • Hyperfine Inc.
  • Bruker BioSpin
  • Time Medical Systems
  • Aspect Imaging
  • Shenzhen Anke High-tech
  • Mediso Medical Imaging
  • Aurora Imaging Tech
  • Esaote-Mindray JV
  • AllTech Medical Systems
  • Paramed Medical Systems